Found 35 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

18 years - 55 years
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication compared to a daily oral dose of another treatment in adults with relapsing forms of multiple sclerosis (RMS). This study aims to measure the annualized relapse rate (ARR) in participants aged 18 to 55 who have been diagnosed with RMS.Participants will …
18 years or above
All genders
Phase 3
Interventional
This study investigates a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP) in adults who do not respond to standard treatments. The study will compare the investigational medication with a placebo to assess its safety and effectiveness.Participants will be divided into study arms, receiving either the investigational medication or a placebo. …
18 years or above
All genders
Phase 3
Interventional
This study investigates the effectiveness and safety of an investigational medication compared to intravenous immunoglobulin (IVIg) in adults with chronic inflammatory demyelinating polyneuropathy (CIDP). Participants in this study are adults who are already receiving IVIg but continue to experience physical challenges.The study involves comparing the investigational medication to the usual …
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication in adults with non-responsive celiac disease (NRCD) who follow a gluten-free diet. This study aims to understand how the investigational medication affects intestinal damage caused by gluten exposure, as measured by the villous height to crypt depth ratio, and its impact …
18 years - 80 years
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication compared with a placebo in adults with high-risk asthma. This study involves adults aged 18 to 80 years who have asthma but are not eligible for biologic treatments.Participants will receive either the investigational medication or a placebo, which is an inactive …
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the efficacy and safety of an investigational medication in adults with moderate to severe Crohn's Disease (CD). This study compares different doses of the investigational medication with a placebo to determine its effectiveness in managing CD symptoms.Participants will undergo various study procedures, including a Double-Blind (DB) treatment …
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the efficacy and safety of an investigational medication in adults with moderate-to-severe ulcerative colitis. The study aims to evaluate how different doses of the investigational medication can achieve clinical remission in participants.Participants will undergo various procedures, including a screening period and treatment periods. The study involves a …
12 years - 35 years
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication compared to a placebo in adults and adolescents with newly diagnosed Type 1 diabetes (T1D) who are already on insulin therapy. Participants will be randomly assigned to receive one of three different doses of the investigational medication or a placebo, which …
18 years or above
All genders
Phase 3
Interventional
This study investigates the effectiveness and safety of an investigational medication compared to a placebo in treating chronic lung allograft dysfunction (CLAD) in adults who have had a lung transplant. Participants in this study must have had their transplant at least a year ago and must be experiencing progression of …
18 years or above
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication on individuals with chronic rhinosinusitis with nasal polyps (CRSwNP). The purpose of this study is to assess the efficacy, safety, and tolerability of two dosing regimens of the investigational medication compared to a placebo, alongside intranasal corticosteroids (INCS).Participants will be randomly …
1 - 10 of 35